Results 11 to 20 of about 65,545 (257)

Direct oral anticoagulants uptake and an oral anticoagulation paradox [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 2020
Oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation is underutilised. One of the impediments to warfarin therapy is the frequent monitoring required, usually at a specialised warfarin clinic. The advent of direct oral anticoagulants (DOACs) facilitates OAC therapy without an onerous monitoring regimen. This benefit may
Cormac Kennedy   +4 more
openaire   +2 more sources

Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis

open access: yesFrontiers in Pharmacology, 2023
Background: The benefits and risks of starting anticoagulation therapy, such as direct oral anticoagulations (DOACs) or warfarin, in atrial fibrillation (AF) patients with a history of intracranial hemorrhage (ICH) remain controversial.
Qiang Zhou   +6 more
doaj   +1 more source

American Journal of Preventive Cardiology: Area Deprivation Index and Oral Anticoagulation in New Onset Atrial Fibrillation

open access: yesAmerican Journal of Preventive Cardiology, 2022
Objective: Oral anticoagulation is a standard of care for thromboembolic stroke prevention in individuals with atrial fibrillation (AF). Social determinants of health have had limited investigation in AF and particularly in access to anticoagulation.
Toluwa D. Omole   +8 more
doaj   +1 more source

Oral Anticoagulation [PDF]

open access: yesDeutsches Ärzteblatt international, 2018
Much new evidence on oral anticoagulation has come to light in recent years. Non-vitamin-K-dependent oral anti- coagulants (NOAC) have been developed and have been introduced into clinical practice. In this review, we present the current state of the evidence on anticoagulation for various indications with vitamin K antagonists (VKA) and with NOAC.This
Ertunc, Altiok, Nikolaus, Marx
openaire   +2 more sources

Oral anticoagulation – current knowlegde

open access: yesJournal of Education, Health and Sport, 2022
Vitamin K antagonists (VKA) and direct oral anticoagulants (DOAC) are two groups of drugs used in the prevention of thromboembolic events. Although DOACs are currently the preferred option in such prophylaxis, there are still indications for the use of ...
Anna Karaś   +4 more
doaj   +1 more source

Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation

open access: yesClinical and Applied Thrombosis/Hemostasis, 2023
Objective During the first wave of the SARS-CoV-2 pandemic, management of anticoagulation therapy in hospitalized patients with atrial fibrillation (AF) was simplified to low-molecular-weight heparin (LMWH) followed by oral anticoagulation, mainly owing ...
Pável Olivera   +9 more
doaj   +1 more source

Anticoagulation for Left Ventricle Thrombus—Case Series and Literature Review for Use of Direct Oral Anticoagulants

open access: yesJournal of Cardiovascular Development and Disease, 2023
Left ventricular thrombus is a known complication following acute myocardial infarction that can lead to systemic thromboembolism. To obviate the risk of thromboembolism, the patient needs anticoagulation in addition to dual antiplatelet therapy. However,
Akshyaya Pradhan   +6 more
doaj   +1 more source

Novel oral anticoagulants [PDF]

open access: yesInternational Journal of Clinical Practice, 2009
Oral anticoagulants have been used widely for the treatment of venous thromboembolism and stroke prevention. The vitamin K antagonists (VKAs), such as warfarin, have been around for the last 65 years and its efficacy as thromboprophylaxis remained largely unchallenged, at least until recently.
C W, Khoo   +3 more
openaire   +2 more sources

New oral anticoagulants [PDF]

open access: yesCanadian Medical Association Journal, 2015
A CMAJ letter[1][1] from a “little cheese” family physician about new oral anticoagulants versus warfarin, and the response[2][2] from three “big cheese” academic specialists show that readers and authors of guidelines do not always agree.
Thomas L, Perry   +4 more
openaire   +2 more sources

The Association of Preinfection Daily Oral Anticoagulation Use and All-Cause in Hospital Mortality From Novel Coronavirus 2019 at 21 Days: A Retrospective Cohort Study

open access: yesCritical Care Explorations, 2021
Objectives:. Practices regarding anticoagulation use in coronavirus disease 2019 focus primarily on its efficacy in the critically ill without a clear understanding of when to begin anticoagulation. We sought to understand the association of preinfection
Raquel F. Harrison, MD   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy